Maple Rock Capital Partners’s Prothena Corp PRTA Stock Holding History
Bought
Maintained
Sold
Other funds holding PRTA
EC
PAI
AC
Maple Rock Capital Partners's PRTA Position: Q1 2024 in Review
Maple Rock Capital Partners sold out of Prothena Corp (PRTA) in Q1 2024, closing a stake of 373,584 shares — an estimated $13.6M sold.
Maple Rock Capital Partners first reported a position in PRTA in Q1 2022 and held it in 8 quarters. The position peaked at $24.2M in Q3 2022. 169 funds tracked by Wall St. Rank hold PRTA as of Q1 2024.
- Maple Rock Capital Partners reported no remaining Prothena Corp position as of Q1 2024 after selling out during the quarter.
- Maple Rock Capital Partners sold 373,584 Prothena Corp shares in Q1 2024, an estimated $13.6M.
- Maple Rock Capital Partners first reported a position in Prothena Corp in Q1 2022 and held it in 8 quarters.
- Maple Rock Capital Partners's Prothena Corp position peaked at $24.2M in Q3 2022.
- 169 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2024.
Based on Maple Rock Capital Partners's 13F filing for Q1 2024, filed 15 May 2024.